Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

Freedom Capital Markets analyst Keith Hinton has maintained a 'Buy' rating on Inspire Medical Systems (NYSE: INSP) and raised the price target from $71 to $97. This adjustment reflects a positive outlook on the company's performance.